Small nucleolar RNA-derived microRNA hsa-miR-1291 modulates cellular drug disposition through direct targeting of ABC transporter ABCC1
about
microRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessmentThe effects of microRNA on the absorption, distribution, metabolism and excretion of drugsMicroRNAs as regulators and mediators of forkhead box transcription factors function in human cancersMiRNAs and miRNA Polymorphisms Modify Drug ResponseN-methylnicotinamide and nicotinamide N-methyltransferase are associated with microRNA-1291-altered pancreatic carcinoma cell metabolome and suppressed tumorigenesis.Rapid production of novel pre-microRNA agent hsa-mir-27b in Escherichia coli using recombinant RNA technology for functional studies in mammalian cells.Assessing the gene regulatory properties of Argonaute-bound small RNAs of diverse genomic origin.A general approach to high-yield biosynthesis of chimeric RNAs bearing various types of functional small RNAs for broad applications.Chimeric MicroRNA-1291 Biosynthesized Efficiently in Escherichia coli Is Effective to Reduce Target Gene Expression in Human Carcinoma Cells and Improve Chemosensitivity.Bioengineering Novel Chimeric microRNA-34a for Prodrug Cancer Therapy: High-Yield Expression and Purification, and Structural and Functional CharacterizationGenome-wide analysis of differentially expressed miRNA in PLX4720-resistant and parental human thyroid cancer cell lines.Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth.MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective TherapyPotential role of epigenetic mechanisms in the regulation of drug metabolism and transport.MicroRNA-1291 targets the FOXA2-AGR2 pathway to suppress pancreatic cancer cell proliferation and tumorigenesisEpigenetic regulation of ADME-related genes: focus on drug metabolism and transport.Regulation of multidrug resistance by microRNAs in anti-cancer therapymiR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1.MicroRNA: a prognostic biomarker and a possible druggable target for circumventing multidrug resistance in cancer chemotherapyImportance of ABCC1 for cancer therapy and prognosis.H/ACA Box Small Nucleolar RNA 7A Promotes the Self-Renewal of Human Umbilical Cord Mesenchymal Stem Cells.MicroRNAs and Cancer Drug Resistance.Involvement of miR-133a and miR-326 in ADM resistance of HepG2 through modulating expression of ABCC1.ATP-binding cassette transmembrane transporters and their epigenetic control in cancer: an overview.Pharmacogenetics of irinotecan, doxorubicin and docetaxel transporters in Asian and Caucasian cancer patients: a comparative review.Epigenetic regulation of drug transporter expression in human tissues.Pharmacoepigenetics: an element of personalized therapy?miR-7 modulates chemoresistance of small cell lung cancer by repressing MRP1/ABCC1.MicroRNA-1291 promotes endometrial fibrosis by regulating the ArhGAP29-RhoA/ROCK1 signaling pathway in a murine modelmicroRNAs and Acute Myeloid Leukemia Chemoresistance: A Mechanistic Overview.Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors.
P2860
Q26778918-CCF7CF64-9AB2-4A3D-A075-63B3415E97A9Q26822987-EB20BB5D-2A9B-432F-BC91-1EE802CD4031Q28072056-64A53AE8-AF89-40CE-AF9C-59CB6ACF4A29Q28079075-B6C4A129-2892-4D1D-8BDF-5832D51ACE4EQ34260260-AA307D94-737D-4560-BA65-2D65CA143003Q34360047-6131B0C0-4ED3-4E10-B74E-9016BB6BB388Q34882977-F8B01A60-E6B9-40A8-985D-030ED6A16A63Q35476690-2BD96718-42DC-4142-B5EE-ECDB53A20E3DQ35745244-F2DB77CB-E8D3-4C2E-9D6D-A26CE058E1AEQ35897815-920B977C-D05D-49D3-B57E-1115BA4B12F0Q36396159-DAEE5146-039C-4749-B8E3-BF4AC25D890DQ36497652-BB5905C9-0697-45C2-B0A9-B659A6F01EF2Q36618667-C5452490-B543-4B20-8330-56317A434E8BQ37193085-3ADC2EB2-0E4A-4592-B711-F03048AF0AE5Q37564481-1004A37F-9EA2-4532-B19D-24DD914EF9B8Q37576018-70867DCA-D11F-45B7-B7AA-8C06D8C6FA8CQ37587311-7A627680-B54B-44C0-B511-4AAF040DCD07Q37644927-CE21E2F6-B225-4C00-84A4-659BBF53C64FQ38172970-BCB3FAD6-32BA-454B-9A1A-AEA767D8CDECQ38199535-FE91FDB5-F27C-4C76-BA33-D572908F5AE9Q38291092-9AF29672-BEAD-45DF-980D-85E9E73867FAQ38748118-A599726F-3EE1-40E9-8139-7279B17DA5D6Q38906160-41443149-98D5-41F4-8EB1-1284968ACA0DQ38908841-A49D7637-E6E4-4E57-84B4-658BC40FDE8CQ38933314-BA7F39E6-A819-4A8A-AFD2-C17E1F213582Q38942246-E4E20F45-1E9F-4473-BD1C-41FF6524866DQ39012550-04B4FC8A-DB49-4217-93D4-D39E00EFAF35Q40800119-E8AA161A-E729-4DE5-9B4D-14C592B8744FQ42679326-AEA8E1C7-2BBA-457D-A46F-BA1DE55FB186Q47375547-1552F1F1-5015-4060-9BA6-28CA59A6684FQ55403266-F2139B98-C636-4753-90D4-D97C5211BC25
P2860
Small nucleolar RNA-derived microRNA hsa-miR-1291 modulates cellular drug disposition through direct targeting of ABC transporter ABCC1
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Small nucleolar RNA-derived mi ...... eting of ABC transporter ABCC1
@en
Small nucleolar RNA-derived mi ...... ting of ABC transporter ABCC1.
@nl
type
label
Small nucleolar RNA-derived mi ...... eting of ABC transporter ABCC1
@en
Small nucleolar RNA-derived mi ...... ting of ABC transporter ABCC1.
@nl
prefLabel
Small nucleolar RNA-derived mi ...... eting of ABC transporter ABCC1
@en
Small nucleolar RNA-derived mi ...... ting of ABC transporter ABCC1.
@nl
P2093
P2860
P356
P1476
Small nucleolar RNA-derived mi ...... eting of ABC transporter ABCC1
@en
P2093
P2860
P304
P356
10.1124/DMD.113.052092
P577
2013-05-16T00:00:00Z